Income Statement Bharat Rasayan Limited

Stocks

BHARATRAS

INE838B01021

Agricultural Chemicals

Market Closed - NSE India S.E. 12:05:07 01/10/2026 BST			5-day change	1st Jan Change
998.60 ^INR	-0.53%		-11.94%	-55.24%

09-21	Bharat Rasayan Limited(BSE:590021) dropped from S&P Global BMI Index	CI
09-01	Bharat Rasayan Limited announces Annual dividend, payable on September 24, 2026	CI

688bdb0a66fa51bdd87b291a0.-Dj2cAZClXsEaYdmWSlEZ2em55lj0tzqCe__hynP-R0.oUiURWVwpi91JMoFE253KgOQt8sZqJGSOYnIz1CBqnqBD8A_Qy_aCF4F7A

Published financial data: BHARAT RASAYAN LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	13.01B	12.34B	10.45B	11.73B	12.42B
Total Revenues	13.01B	12.34B	10.45B	11.73B	12.42B
Cost of Goods Sold, Total	8.43B	8.39B	7.21B	7.77B	8.06B
Gross Profit	4.59B	3.95B	3.24B	3.96B	4.36B
Selling General & Admin Expenses, Total	930M	888M	869M	874M	925M
Provision for Bad Debts	-	-	-	-	-
Depreciation & Amortization - (IS)	249M	260M	258M	270M	264M
Other Operating Expenses	1.08B	1.09B	1.18B	1.3B	1.42B
Other Operating Expenses, Total	2.26B	2.24B	2.31B	2.45B	2.61B
Operating Income	2.32B	1.71B	928M	1.51B	1.76B
Interest Expense, Total	-68.18M	-58.07M	-29.57M	-47.16M	-45.93M
Interest And Investment Income	3.85M	4.33M	4.71M	7.46M	2.8M
Net Interest Expenses	-64.32M	-53.74M	-24.86M	-39.69M	-43.13M
Income (Loss) On Equity Invest.	-11.49M	-62.22M	139M	158M	27.99M
Currency Exchange Gains (Loss)	128M	176M	135M	84.93M	203M
Other Non Operating Income (Expenses)	120K	4.64M	-	8.61M	-
EBT, Excl. Unusual Items	2.37B	1.78B	1.18B	1.72B	1.94B
Gain (Loss) On Sale Of Investments	1.63M	7.78M	55.97M	125M	178M
Gain (Loss) On Sale Of Assets	-	-	194K	452K	-64K
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-39.34M	-45.77M	-	-	-188M
EBT, Incl. Unusual Items	2.34B	1.74B	1.23B	1.85B	1.93B
Income Tax Expense	577M	494M	278M	441M	476M
Earnings From Continuing Operations	1.76B	1.25B	955M	1.41B	1.46B
Net Income to Company	1.76B	1.25B	955M	1.41B	1.46B
Net Income - (IS)	1.76B	1.25B	955M	1.41B	1.46B
Net Income to Common Incl Extra Items	1.76B	1.25B	955M	1.41B	1.46B
Net Income to Common Excl. Extra Items	1.76B	1.25B	955M	1.41B	1.46B
Per Share Items
Net EPS - Basic	105.89	74.98	57.47	84.79	87.68
Basic EPS - Continuing Operations	105.89	74.98	57.47	84.79	87.68
Basic Weighted Average Shares Outstanding	16.62M	16.62M	16.62M	16.62M	16.62M
Net EPS - Diluted	105.88	74.97	57.46	84.78	87.68
Diluted EPS - Continuing Operations	105.88	74.97	57.46	84.78	87.68
Diluted Weighted Average Shares Outstanding	16.62M	16.62M	16.62M	16.62M	16.62M
Normalized Basic EPS	89.29	66.86	44.26	64.85	73.08
Normalized Diluted EPS	89.29	66.86	44.26	64.85	73.08
Dividend Per Share	0.38	0.38	0.38	0.38	1.5
Payout Ratio	0.35	0.5	0.65	0.44	0.43
Supplemental Items
EBITDA	2.57B	1.97B	1.18B	1.78B	2.02B
EBITA	2.32B	1.71B	928M	1.51B	1.76B
EBIT	2.32B	1.71B	928M	1.51B	1.76B
EBITDAR	2.58B	1.98B	1.19B	1.79B	2.03B
Total Revenues (As Reported)	13.17B	12.54B	10.66B	11.99B	12.83B
Effective Tax Rate - (Ratio)	24.69	28.39	22.55	23.83	24.64
Total Current Taxes	579M	498M	253M	397M	435M
Total Deferred Taxes	-1.75M	-4.33M	25.06M	43.48M	41.62M
Normalized Net Income	1.48B	1.11B	736M	1.08B	1.21B
Non-Cash Pension Expense	1.77M	3.51M	6.05M	7.97M	661K
Supplemental Operating Expense Items
Advertising Expense	6.13M	9.07M	15.78M	12.57M	12.47M
Selling and Marketing Expenses	6.13M	9.07M	15.78M	12.57M	12.47M
Research And Development Expense From Footnotes	23.22M	24.2M	22.34M	32.76M	41.73M
Net Rental Expense, Total	9.67M	8.68M	8.71M	7.7M	7.78M
Imputed Operating Lease Interest Expense	4.54M	4M	3.8M	3.51M	6.61M
Imputed Operating Lease Depreciation	5.12M	4.68M	4.91M	4.19M	1.17M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	3.35M	186M	324M	554M	228M
Short Term Investments	-	300M	922M	2.3B	2.5B
Total Cash And Short Term Investments	3.35M	486M	1.25B	2.86B	2.72B
Accounts Receivable, Total	4.64B	3.25B	3.94B	4.19B	3.85B
Other Receivables	305M	593M	948M	703M	494M
Total Receivables	4.94B	3.84B	4.88B	4.9B	4.35B
Inventory	2.77B	3.23B	2.67B	2.9B	3.31B
Prepaid Expenses	13.35M	16.2M	13.49M	14.97M	11.66M
Other Current Assets, Total	278M	331M	258M	259M	215M
Total Current Assets	8.01B	7.91B	9.07B	10.93B	10.6B
Gross Property Plant And Equipment	4.37B	4.58B	4.85B	5.18B	5.91B
Accumulated Depreciation	-1.98B	-2.23B	-2.49B	-2.73B	-2.99B
Net Property Plant And Equipment	2.39B	2.35B	2.36B	2.45B	2.92B
Long-term Investments	433M	370M	509M	684M	748M
Other Intangibles, Total	1.5M	1.02M	854K	805K	805K
Other Long-Term Assets, Total	63.99M	106M	33.53M	21.74M	56.8M
Total Assets	10.9B	10.74B	11.97B	14.08B	14.33B
Liabilities
Accounts Payable, Total	682M	748M	728M	1.42B	968M
Accrued Expenses, Total	28.76M	27.73M	31.63M	83.62M	43.78M
Short-term Borrowings	1.73B	279M	805M	852M	12.26M
Current Income Taxes Payable	71.56M	22.07M	-	9.89M	15.92M
Unearned Revenue Current, Total	121M	92.75M	10.17M	19M	880K
Other Current Liabilities	457M	535M	396M	223M	323M
Total Current Liabilities	3.09B	1.71B	1.97B	2.61B	1.36B
Long-Term Debt	10M	-	-	-	-
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	88.46M	84.13M	109M	153M	194M
Other Non Current Liabilities	12.92M	13.86M	15.97M	20.03M	20.52M
Total Liabilities	3.2B	1.8B	2.1B	2.78B	1.58B
Common Stock, Total	41.55M	41.55M	41.55M	41.55M	83.1M
Retained Earnings	7.66B	8.89B	9.84B	11.26B	12.66B
Comprehensive Income and Other	935K	936K	935K	935K	-
Total Common Equity	7.7B	8.93B	9.88B	11.3B	12.75B
Total Equity	7.7B	8.93B	9.88B	11.3B	12.75B
Total Liabilities And Equity	10.9B	10.74B	11.97B	14.08B	14.33B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	16.62M	16.62M	16.62M	16.62M	16.62M
ECS Total Common Shares Outstanding	16.62M	16.62M	16.62M	16.62M	16.62M
Book Value / Share	463.28	537.46	594.36	679.86	766.94
Tangible Book Value	7.7B	8.93B	9.88B	11.3B	12.75B
Tangible Book Value Per Share	463.19	537.39	594.31	679.81	766.89
Total Debt	1.74B	279M	805M	852M	12.26M
Net Debt	1.73B	-207M	-442M	-2B	-2.71B
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.57M	7.76M	5.93M	1.62M	-1.55M
Debt Equivalent Oper. Leases	77.35M	69.46M	69.69M	61.59M	62.24M
Equity Method Investments, Total	433M	370M	509M	684M	712M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	790M	1.02B	1B	777M	1.19B
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	1.8B	1.96B	1.53B	2B	1.93B
Inventories - Others	182M	254M	138M	125M	185M
Land - (BS)	273M	273M	272M	272M	272M
Buildings, Total	1.05B	1.06B	1.08B	1.08B	1.1B
Machinery, Total	2.93B	3.14B	3.43B	3.67B	4.08B
Full Time Employees	885	797	816	861	903

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	1.76B	1.25B	955M	1.41B	1.46B
Depreciation & Amortization - CF	249M	260M	258M	270M	264M
Amortization of Goodwill and Intangible Assets - (CF)	602K	471K	170K	49K	-
Depreciation & Amortization, Total	249M	260M	258M	270M	264M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-116K	-	194K	-452K	64K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	11.49M	62.22M	-139M	-158M	-27.99M
Other Operating Activities, Total	-65.97M	-140M	-120M	19.64M	-116M
Change In Accounts Receivable	-1.68B	1.39B	-686M	-256M	338M
Change In Inventories	-1.09B	-459M	565M	-237M	-402M
Change In Accounts Payable	69.65M	66.52M	-19.82M	693M	-454M
Change in Other Net Operating Assets	88.91M	-289M	-402M	-19.97M	261M
Cash from Operations	-655M	2.13B	411M	1.72B	1.32B
Capital Expenditure	-557M	-235M	-271M	-357M	-735M
Sale of Property, Plant, and Equipment	2.94M	14.07M	1.04M	3.12M	1.82M
Investment in Marketable and Equity Securities, Total	1.06B	-299M	-622M	-1.38B	-231M
Other Investing Activities, Total	6.4M	-85.1M	-5.55M	163M	6.14M
Cash from Investing	511M	-605M	-897M	-1.57B	-958M
Short Term Debt Issued, Total	-	-	525M	47.45M	-
Long-Term Debt Issued, Total	1.15B	-	-	-	-
Total Debt Issued	1.15B	-	525M	47.45M	-
Short Term Debt Repaid, Total	-	-	-	-	-840M
Long-Term Debt Repaid, Total	-	-1.46B	-	-	-
Total Debt Repaid	-	-1.46B	-	-	-840M
Repurchase of Common Stock	-1.33B	-	-	-	-
Common Dividends Paid	-6.23M	-6.23M	-6.23M	-6.23M	-6.23M
Common & Preferred Stock Dividends Paid	-6.23M	-6.23M	-6.23M	-6.23M	-6.23M
Other Financing Activities, Total	-68.18M	-58.07M	-29.57M	-47.16M	-45.93M
Cash from Financing	-248M	-1.52B	490M	-5.94M	-892M
Foreign Exchange Rate Adjustments	128M	176M	135M	84.93M	203M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-263M	182M	139M	230M	-327M
Supplemental Items
Cash Interest Paid	68.18M	58.07M	29.57M	47.16M	45.93M
Cash Income Tax Paid (Refund)	578M	505M	286M	377M	429M
Levered Free Cash Flow	-1.49B	1.71B	-112M	1.17B	384M
Unlevered Free Cash Flow	-1.44B	1.75B	-93.28M	1.2B	413M
Change In Net Working Capital	2.59B	-649M	660M	-340M	213M
Net Debt Issued / Repaid	1.15B	-1.46B	525M	47.45M	-840M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	14.53	9.92	5.11	7.26	7.72
Return on Total Capital	16.78	11.49	5.83	8.28	8.81
Return On Equity %	23.51	14.98	10.15	13.31	12.12
Return on Common Equity	23.51	14.98	10.15	13.31	12.12
Margin Analysis
Gross Profit Margin %	35.24	32.02	30.98	33.76	35.11
SG&A Margin	7.14	7.2	8.32	7.45	7.45
EBITDA Margin %	19.76	15.99	11.34	15.19	16.25
EBITA Margin %	17.85	13.89	8.88	12.89	14.14
EBIT Margin %	17.85	13.88	8.88	12.89	14.14
Income From Continuing Operations Margin %	13.53	10.1	9.14	12.01	11.73
Net Income Margin %	13.53	10.1	9.14	12.01	11.73
Net Avail. For Common Margin %	13.53	10.1	9.14	12.01	11.73
Normalized Net Income Margin	11.41	9	7.04	9.19	9.78
Levered Free Cash Flow Margin	-11.42	13.85	-1.07	9.97	3.1
Unlevered Free Cash Flow Margin	-11.09	14.14	-0.89	10.22	3.33
Asset Turnover
Asset Turnover	1.3	1.14	0.92	0.9	0.87
Fixed Assets Turnover	5.82	5.21	4.43	4.88	4.63
Receivables Turnover (Average Receivables)	3.43	3.13	2.91	2.89	3.09
Inventory Turnover (Average Inventory)	3.78	2.8	2.45	2.79	2.6
Short Term Liquidity
Current Ratio	2.59	4.64	4.6	4.19	7.78
Quick Ratio	1.6	2.54	3.11	2.97	5.19
Operating Cash Flow to Current Liabilities	-0.21	1.25	0.21	0.66	0.97
Days Sales Outstanding (Average Receivables)	106.5	116.62	125.9	126.47	118.25
Days Outstanding Inventory (Average Inventory)	96.54	130.57	149.68	130.83	140.63
Average Days Payable Outstanding	24.82	29.48	40.66	48.99	51.53
Cash Conversion Cycle (Average Days)	178.23	217.71	234.93	208.31	207.35
Long Term Solvency
Total Debt/Equity	22.55	3.13	8.15	7.54	0.1
Total Debt / Total Capital	18.4	3.03	7.53	7.01	0.1
LT Debt/Equity	0.13	-	-	-	-
Long-Term Debt / Total Capital	0.11	-	-	-	-
Total Liabilities / Total Assets	29.34	16.79	17.5	19.75	11.01
EBIT / Interest Expense	34.06	29.51	31.38	32.08	38.22
EBITDA / Interest Expense	37.72	34	40.1	37.8	43.96
(EBITDA - Capex) / Interest Expense	29.55	29.95	30.95	30.23	27.95
Total Debt / EBITDA	0.68	0.14	0.68	0.48	0.01
Net Debt / EBITDA	0.67	-0.1	-0.37	-1.12	-1.34
Total Debt / (EBITDA - Capex)	0.86	0.16	0.88	0.6	0.01
Net Debt / (EBITDA - Capex)	0.86	-0.12	-0.48	-1.41	-2.11
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	19.15	-5.13	-15.37	12.29	5.87
Gross Profit, 1 Yr. Growth %	12.38	-13.79	-18.14	22.39	10.1
EBITDA, 1 Yr. Growth %	6.7	-22.08	-39.92	50.38	13.28
EBITA, 1 Yr. Growth %	7.84	-24.95	-45.84	63.02	16.06
EBIT, 1 Yr. Growth %	7.88	-24.95	-45.83	63.05	16.06
Earnings From Cont. Operations, 1 Yr. Growth %	7.39	-29.19	-23.35	47.54	3.41
Net Income, 1 Yr. Growth %	7.39	-29.19	-23.35	47.54	3.41
Normalized Net Income, 1 Yr. Growth %	10.6	-23.89	-33.72	46.52	12.7
Diluted EPS Before Extra, 1 Yr. Growth %	9.81	-29.19	-23.35	47.54	3.41
Accounts Receivable, 1 Yr. Growth %	56.88	-29.91	21.11	6.5	-8.07
Inventory, 1 Yr. Growth %	64.45	16.56	-17.48	8.9	13.84
Net Property, Plant and Equip., 1 Yr. Growth %	14.62	-1.62	0.49	3.57	19.19
Total Assets, 1 Yr. Growth %	20.04	-1.1	11.53	17.6	1.73
Tangible Book Value, 1 Yr. Growth %	5.87	16.02	10.59	14.39	12.81
Common Equity, 1 Yr. Growth %	5.88	16.01	10.59	14.39	12.81
Cash From Operations, 1 Yr. Growth %	-138.46	-425.94	-80.75	318.77	-23.25
Capital Expenditures, 1 Yr. Growth %	83.04	-57.78	15.04	31.89	105.96
Levered Free Cash Flow, 1 Yr. Growth %	-231.43	-213.24	-106.54	-1.15K	-67.12
Unlevered Free Cash Flow, 1 Yr. Growth %	-225.11	-219	-105.35	-1.39K	-65.53
Dividend Per Share, 1 Yr. Growth %	0	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.48	6.32	-10.4	-2.52	9.03
Gross Profit, 2 Yr. CAGR %	10.44	-1.57	-15.99	0.1	16.08
EBITDA, 2 Yr. CAGR %	5.82	-9.5	-31.6	-4.95	30.52
EBITA, 2 Yr. CAGR %	5.64	-10.79	-36.27	-6.03	37.55
EBIT, 2 Yr. CAGR %	5.74	-10.77	-36.26	-6.02	37.56
Earnings From Cont. Operations, 2 Yr. CAGR %	5.66	-12.8	-26.33	6.34	23.52
Net Income, 2 Yr. CAGR %	5.66	-12.8	-26.33	6.34	23.52
Normalized Net Income, 2 Yr. CAGR %	6.74	-9	-29.02	-1.45	28.5
Diluted EPS Before Extra, 2 Yr. CAGR %	6.84	-11.82	-26.33	6.34	23.52
Accounts Receivable, 2 Yr. CAGR %	36.03	4.86	-7.86	13.57	-1.05
Inventory, 2 Yr. CAGR %	31.49	38.45	-1.92	-5.2	11.34
Net Property, Plant and Equip., 2 Yr. CAGR %	4.01	6.19	-0.57	2.02	11.11
Total Assets, 2 Yr. CAGR %	20.39	8.74	5.03	14.52	9.38
Tangible Book Value, 2 Yr. CAGR %	16.85	10.83	13.27	12.47	13.6
Common Equity, 2 Yr. CAGR %	16.83	10.83	13.27	12.47	13.59
Cash From Operations, 2 Yr. CAGR %	-50.07	11.96	-20.78	-10.21	79.27
Capital Expenditures, 2 Yr. CAGR %	-2.37	-12.09	-30.31	23.18	64.82
Levered Free Cash Flow, 2 Yr. CAGR %	-4.87	22.97	-72.79	-17.27	85.47
Unlevered Free Cash Flow, 2 Yr. CAGR %	-8.92	23.03	-74.78	-17.11	110.46
Dividend Per Share, 2 Yr. CAGR %	0	0	0	0	100
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.46	0.53	-1.47	-3.4	0.2
Gross Profit, 3 Yr. CAGR %	14.12	1.69	-7.44	-4.77	3.33
EBITDA, 3 Yr. CAGR %	11.08	-4.92	-21.07	-11.06	0.78
EBITA, 3 Yr. CAGR %	10.82	-6.26	-24.48	-12.84	0.82
EBIT, 3 Yr. CAGR %	10.86	-6.21	-24.46	-12.83	0.83
Earnings From Cont. Operations, 3 Yr. CAGR %	16.42	-7.54	-16.47	-7.14	5.36
Net Income, 3 Yr. CAGR %	16.42	-7.54	-16.47	-7.14	5.36
Normalized Net Income, 3 Yr. CAGR %	14.81	-5.16	-18.16	-9.62	3.06
Diluted EPS Before Extra, 3 Yr. CAGR %	17.29	-6.85	-15.84	-7.14	5.36
Accounts Receivable, 3 Yr. CAGR %	18.44	9.06	10.02	-3.31	5.84
Inventory, 3 Yr. CAGR %	9.66	26.31	16.52	1.56	0.76
Net Property, Plant and Equip., 3 Yr. CAGR %	8.94	2.1	4.26	0.79	7.45
Total Assets, 3 Yr. CAGR %	12.98	12.61	9.67	9.06	10.09
Tangible Book Value, 3 Yr. CAGR %	23.56	16.57	10.75	13.64	12.59
Common Equity, 3 Yr. CAGR %	23.5	16.56	10.75	13.64	12.58
Cash From Operations, 3 Yr. CAGR %	7.76	-6.69	-37.74	38	-14.79
Capital Expenditures, 3 Yr. CAGR %	5.26	-26.17	-3.85	-13.8	46.2
Levered Free Cash Flow, 3 Yr. CAGR %	5.75	1.36	-53.76	-8.16	-39.17
Unlevered Free Cash Flow, 3 Yr. CAGR %	7.63	0.12	-56.75	-6.51	-38.13
Dividend Per Share, 3 Yr. CAGR %	0	0	0	0	58.74
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.96	9.19	1.04	-0.7	2.61
Gross Profit, 5 Yr. CAGR %	21.68	7.69	0.96	1.05	1.34
EBITDA, 5 Yr. CAGR %	18.4	4.52	-8.78	-4.94	-3.48
EBITA, 5 Yr. CAGR %	19.83	3.87	-11.47	-6.18	-4.01
EBIT, 5 Yr. CAGR %	19.82	3.87	-11.45	-6.15	-4
Earnings From Cont. Operations, 5 Yr. CAGR %	26.4	4.85	-3.05	-2.22	-2.32
Net Income, 5 Yr. CAGR %	26.4	4.85	-3.05	-2.22	-2.32
Normalized Net Income, 5 Yr. CAGR %	23.11	5.93	-5.59	-3.72	-1.97
Diluted EPS Before Extra, 5 Yr. CAGR %	26.97	5.32	-2.62	-1.78	-1.88
Accounts Receivable, 5 Yr. CAGR %	31.01	7.96	7.12	10.84	5.45
Inventory, 5 Yr. CAGR %	27.01	27.96	4.87	12.61	14.42
Net Property, Plant and Equip., 5 Yr. CAGR %	12.57	8.76	5.03	2.07	6.94
Total Assets, 5 Yr. CAGR %	24.15	16.34	9.64	13.37	9.55
Tangible Book Value, 5 Yr. CAGR %	30.86	24.56	19.34	14.91	11.88
Common Equity, 5 Yr. CAGR %	30.85	24.53	19.3	14.91	11.88
Cash From Operations, 5 Yr. CAGR %	32.91	49.25	-4.72	-8.11	-4.95
Capital Expenditures, 5 Yr. CAGR %	34.85	-10.5	-10.75	-9.4	19.28
Levered Free Cash Flow, 5 Yr. CAGR %	40.59	37.95	-38.36	-6.56	-19.4
Unlevered Free Cash Flow, 5 Yr. CAGR %	49.15	44.95	-39.57	-7.17	-18.56
Dividend Per Share, 5 Yr. CAGR %	0	0	0	0	31.95